Drugs / Fang yi qing feng shi granule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02029599 | Mar 2014 → Aug 2015 | rheumatoid arthritis | Maoxiang Group Jilin Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fang yi qing feng shi granule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02029599 ↗ |
| Known as | Fang yi qing feng shi granules | “Fang yi qing feng shi granules is the chinese patent medicine” NCT02029599 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Fang yi qing feng shi granules is the chinese patent medicine” NCT02029599 ↗ |
| Route | Oral | “Fang yi qing feng shi granule, Oral,10g, 3 times a day” NCT02029599 ↗ |